Rapid Bio-Decontamination Service Proven Effective Against Coronavirus

摘要

With the number of COVID-19 cases rising globally,Bioquell,an Ecolab solution,is offering a proven solution to help eradicate coronavirus in a range of healthcare,life sciences and pharmaceutical environments,including isolation rooms and public spaces.Utilising the company's scientifically proven 35% Hydrogen Peroxide Vapour technology,Bioquell's Rapid Bio-decontamination Service(RBDS)is helping to provide microbiologically clean surfaces and spaces for patients and staff.A study on the virucidal efficacy of Bioquell's Hydrogen Peroxide Vapour was published in the April 2014 issue of The Journal of Hospital Infection.The study evaluated the in-vitro efficacy of Bioquell Hydrogen Peroxide Vapour for the in-activation of a number of structurally distinct viruses that could impact the healthcare,veterinary and public sectors,including feline calicivirus(FCV);human adenovirus type 1;transmissible gastroenteritis coronavirus of pigs(TGEV: a severe acute respiratory syndrome coronavirus(SARS-CoV surrogate);avian influenza virus(AIV);and swine influenza virus(SwIV).The findings showed that after exposure to Bioquell's Hydrogen Peroxide Vapour,no viable viruses were identified.The technology has also been evaluated by the UK Government's Biosafety Group at the Centre for Emergency Preparedness and Response,Porton Down,using the non-enveloped virus surrogate MS2 phage,with full inactivation achieved.